Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Real-World Study on Reducing the Risk of Liver Cancer in Chronic Hepatitis B Patients With a Family History of HBV-Related Liver Cancer.

NCT07007286 is registered in ClinicalTrials.gov with Peking University First Hospital as lead sponsor.

NCT NCT07007286
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07007286 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Real-World Study on Reducing the Risk of Liver Cancer in Chronic Hepatitis B Patients With a Family History of HBV-Related Liver Cancer.
Lead sponsor
Peking University First Hospital
Phase
Observational
Overall status
Not yet recruiting
Start date
June 30, 2025
Completion date
December 31, 2032
Enrollment
1,500 (estimated)
Sites
555

Conditions

As the registry lists them; a condition with its own page is linked.

hbv, hcc